Palliative care and end-of-life care in adults with malignant brain tumors

JAF Koekkoek, PB van der Meer, A Pace… - Neuro …, 2023 - academic.oup.com
Background This systematic review provides updated insights, from the published literature
in the past 5 years, based on the 2017 European Association of Neuro-Oncology (EANO) …

Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis

P Palmisciano, AS Haider, CD Nwagwu… - Journal of Neuro …, 2021 - Springer
Purpose Radiation necrosis (RN) represents a serious post-radiotherapy complication in
patients with brain metastases. Bevacizumab and laser interstitial thermal therapy (LITT) are …

[HTML][HTML] Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis

L Nichelli, S Casagranda - Current Opinion in Oncology, 2021 - journals.lww.com
Current emerging MRI tools for radionecrosis and pseudoprogr... : Current Opinion in Oncology
Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis : Current …

Neurotoxicity from old and new radiation treatments for brain tumors

R Soffietti, A Pellerino, F Bruno, A Mauro… - International Journal of …, 2023 - mdpi.com
Research regarding the mechanisms of brain damage following radiation treatments for
brain tumors has increased over the years, thus providing a deeper insight into the …

DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment

D Bernhardt, L König, AL Grosu, S Rieken… - Strahlentherapie und …, 2022 - Springer
Abstract Purpose The Working Group for Neurooncology of the German Society for
Radiation Oncology (DEGRO; AG NRO) in cooperation with members of the …

Can low‐dose intravenous bevacizumab be as effective as high‐dose bevacizumab for cerebral radiation necrosis?

M Gao, X Wang, X Wang, G Niu, X Liu, S Zhao… - Cancer …, 2024 - Wiley Online Library
Although intravenous bevacizumab (IVBEV) is the most promising treatment for cerebral
radiation necrosis (CRN), there is no conclusion on the optimal dosage. Our retrospective …

[HTML][HTML] Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I/II study

JJ Lin, A Muzikansky, E Kennedy, H Kuberski… - ESMO open, 2022 - Elsevier
Background Alectinib, a second-generation anaplastic lymphoma kinase (ALK) tyrosine
kinase inhibitor (TKI), is highly effective in advanced ALK-rearranged non-small-cell lung …

[HTML][HTML] Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma

EJ Vaios, KA Batich, AF Buckley, A Dunn-Pirio… - Oncotarget, 2022 - ncbi.nlm.nih.gov
Importance: Radiation necrosis (RN) is a rare but serious adverse effect following treatment
with radiation therapy. No standard of care exists for the management of RN, and efforts to …

Radiation-induced optic neuropathy: a review

AR Carey, BR Page, N Miller - British Journal of Ophthalmology, 2023 - bjo.bmj.com
Radiation is a commonly used treatment modality for head and neck as well as CNS
tumours, both benign and malignant. As newer oncology treatments such as …

[HTML][HTML] Steroid utility, immunotherapy, and brain tumor management: an update on conflicting therapies

M Goldman, B Lucke-Wold… - … of Targeted Anti …, 2022 - ncbi.nlm.nih.gov
Steroid use is a widely accepted practice for both the treatment and prevention of tumor-
induced edema, but there are many unknowns regarding their current clinical utility with …